SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation.
about
Ribonucleocapsid Formation of Severe Acute Respiratory Syndrome Coronavirus through Molecular Action of the N-Terminal Domain of N ProteinNovel Immunodominant Peptide Presentation Strategy: a Featured HLA-A*2402-Restricted Cytotoxic T-Lymphocyte Epitope Stabilized by Intrachain Hydrogen Bonds from Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid ProteinConserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentHLA class I supertypes: a revised and updated classification.Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL.Porcine major histocompatibility complex (MHC) class I molecules and analysis of their peptide-binding specificitiesHuman leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strengthPredictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?MHC-bound antigens and proteomics for novel target discovery.Information technologies for vaccine research.NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11Experimental discovery of T-cell epitopes: combining the best of classical and contemporary approaches.HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicityMHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination.Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development.Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity.Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes.Prediction of MHC binding peptide using Gibbs motif sampler, weight matrix and artificial neural network.TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates.Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology.High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination.Modeling the adaptive immune system: predictions and simulations.
P2860
Q27641213-5735A43B-063D-428A-8BE7-02714A77C35BQ27664523-0F660679-611E-48E1-B881-2171E4BF0A6BQ30226873-3D718F7D-F5C1-472B-B9C4-069D6E662404Q33315730-5E4A5220-18A8-45AB-A2E1-2E756D859483Q33459720-7E0AC8DC-91D4-4F1A-BA57-44944DB2CA1FQ33697909-397FDA55-A1C6-4EF3-B75A-301988FE5DB4Q33955589-F257711D-F549-4F2F-9C96-FD5D5D3C8AACQ34062468-C30DBF34-F9E5-4E1C-8715-215E6E5F9C6AQ35813585-D6B3495F-2EEF-40CD-86AD-0C1CA41D3C4CQ35911151-96267B70-43FA-4F84-BD67-BF625ED63BE2Q36198676-510FE7B7-C3D2-4E41-81D1-440B545CA5C4Q36749382-FF276E3B-B3AA-4112-8ED0-11F2B171FABFQ36899098-527D782F-DF7E-4137-A078-CE0977768E16Q37414385-D5A8E2ED-C686-4122-92A3-C6CE0799B94AQ37443937-ADF017F9-76D8-44F4-8E6C-4BE670E55D6CQ37844333-BF779B14-A8C9-4F79-B11A-6032786984D0Q39606015-BD0DE8DB-691F-479B-A7B8-3CAEB0897709Q39849181-A1441471-3011-47A6-BF03-2C3AE8F99435Q40447732-A2403445-4967-44B7-87EA-52E78867C6BDQ41807238-2AC31641-F16C-4C30-8346-3FA5D9F17ACBQ41827687-AE51CA59-58FF-4A8F-B43E-F615AAE65912Q42040401-4CD6F300-ED07-42AF-B71D-15BA4C01979BQ45386540-FC1836CC-C7F2-43B2-BC59-1CC9559C8E45Q48372980-43DE83CE-03C8-4C43-8685-77E43D75A23C
P2860
SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
SARS CTL vaccine candidates; H ...... ng and biochemical validation.
@en
SARS CTL vaccine candidates; H ...... ng and biochemical validation.
@nl
type
label
SARS CTL vaccine candidates; H ...... ng and biochemical validation.
@en
SARS CTL vaccine candidates; H ...... ng and biochemical validation.
@nl
prefLabel
SARS CTL vaccine candidates; H ...... ng and biochemical validation.
@en
SARS CTL vaccine candidates; H ...... ng and biochemical validation.
@nl
P2093
P2860
P50
P1433
P1476
SARS CTL vaccine candidates; H ...... ng and biochemical validation.
@en
P2093
Justesen S
Lamberth K
Lundegaard C
Sylvester-Hvid C
Thomadsen H
P2860
P304
P356
10.1111/J.0001-2815.2004.00221.X
P577
2004-05-01T00:00:00Z